| Dr Oleg Fuzaylov, MD | |
|
9701 66th Ave, Rego Park, NY 11374-4245 | |
| (718) 275-5200 | |
| (718) 275-6864 |
| Full Name | Dr Oleg Fuzaylov |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine & Rehabilitation |
| Location | 9701 66th Ave, Rego Park, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912082504 | NPI | - | NPPES |
| 02150154 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 220254 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Oleg Fuzaylov, MD 9701 66th Ave, Rego Park, NY 11374-4245 Ph: (718) 275-5200 | Dr Oleg Fuzaylov, MD 9701 66th Ave, Rego Park, NY 11374-4245 Ph: (718) 275-5200 |
News Archive
Exercise helps prevent weight regain after dieting by reducing appetite and by burning fat before burning carbohydrates, according to a new study with rats. Burning fat first and storing carbohydrates for use later in the day slows weight regain and may minimize overeating by signaling a feeling of fullness to the brain.
Protalix BioTherapeutics, Inc., announced today positive top-line results from the Company's pivotal Phase III clinical trial of UPLYSO (taliglucerase alfa, previously referred to as prGCD) in treatment naive patients diagnosed with Gaucher disease.
Oticon has been rated as best in value, quality, patient satisfaction and more in a survey of more than 500 hearing care professionals. Hearing Tracker announced the latest in a series of Hearing Tracker surveys that explore factors hearing care professionals consider when choosing between leading hearing aid brands. Oticon ranked number one in multiple categories, boasting a 68% rating for patient satisfaction.
Today, Boehringer Ingelheim has announced the submission of a Marketing Authorisation Application to the European Medicines Agency (EMA) for approval of afatinib, the first irreversible ErbB Family Blocker, as a treatment for patients with EGFR (ErbB1) mutation positive non-small cell lung cancer (NSCLC). Afatinib has demonstrated unprecedented efficacy versus chemotherapy in the Phase III LUX-Lung 3 registration trial, which provides pivotal support for this submission.
Studies have shown that an early age of drinking initiation (ADI) increases the chance of developing an alcohol use disorder (AUD).
› Verified 4 days ago
Dr. Oliver Masaba, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 9520 Queens Blvd, Rego Park, NY 11374 Phone: 718-459-1280 | |
Dmitriy Fuzaylov, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 9701 66th Ave, Rego Park, NY 11374 Phone: 718-275-5200 Fax: 718-275-6864 | |
Diana Barayeva, D.O Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 6441 Saunders St, Apt 306, Rego Park, NY 11374 Phone: 646-413-0553 | |
Kevin James Cipriano, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 9525 Queens Blvd, Rego Park, NY 11374 Phone: 718-925-6238 Fax: 929-895-5109 | |
Dr. Klara Sosina, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 6384 Saunders St, Apt. # 2b, Rego Park, NY 11374 Phone: 718-997-7064 | |
Dr. Steven Ross, D.O. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 9520 Queens Blvd, Rego Park, NY 11374 Phone: 718-459-1280 | |
Maryam Rafael Aghalar, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 97-12 63rd Drive, Suite 1-b, Rego Park, NY 11374 Phone: 718-897-7430 Fax: 718-896-0062 |